JP Morgan Chase
PDSB icon

JP Morgan Chase’s PDS Biotechnology PDSB Stock Holding History

JP Morgan Chase’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10 Hold
19
– – ﹤0.01% 7432
2025
Q4 		$15 Sell
19
-600
-97% -$541 ﹤0.01% 7319
2025
Q3 		$625 Hold
619
– – ﹤0.01% 7035
2025
Q2 		$823 Hold
619
– – ﹤0.01% 6641
2025
Q1 		$737 Hold
619
– – ﹤0.01% 6662
2024
Q4 		$1.01K Hold
619
– – ﹤0.01% 6734
2024
Q3 		$2.37K Hold
619
– – ﹤0.01% 6603
2024
Q2 		$1.81K Sell
619
-11,203
-95% -$35.8K ﹤0.01% 6545
2024
Q1 		$46.8K Sell
11,822
-8,253
-41% -$42.5K ﹤0.01% 5972
2023
Q4 		$99.8K Buy
20,075
+1,951
+11% +$9.7K ﹤0.01% 5732
2023
Q3 		$91.5K Sell
18,124
-4,159
-19% -$22.8K ﹤0.01% 5528
2023
Q2 		$112K Buy
+22,283
New +$146K ﹤0.01% 5414
2018
Q2 		– Sell
-1,288
Closed -$31K – 5651
2018
Q1 		$31K Sell
1,288
-17,260
-93% -$4.64M ﹤0.01% 4965
2017
Q4 		$3.48M Sell
18,548
-406
-2% -$81.7K ﹤0.01% 2963
2017
Q3 		$4.06M Buy
18,954
+13,093
+223% +$2.71M ﹤0.01% 2710
2017
Q2 		$1.2M Sell
5,861
-173
-3% -$34.1K ﹤0.01% 3330
2017
Q1 		$1.1M Sell
6,034
-363
-6% -$71.9K ﹤0.01% 3363
2016
Q4 		$1.6M Buy
6,397
+128
+2% +$29.1K ﹤0.01% 3216
2016
Q3 		$1.3M Buy
6,269
+423
+7% +$83.8K ﹤0.01% 3007
2016
Q2 		$1.18M Sell
5,846
-212
-3% -$37.5K ﹤0.01% 3092
2016
Q1 		$1.11M Buy
6,058
+294
+5% +$52.6K ﹤0.01% 3019
2015
Q4 		$1.44M Buy
+5,764
New +$1.86M ﹤0.01% 2934

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase's PDSB Position: Q1 2026 in Review

JP Morgan Chase held its PDS Biotechnology (PDSB) position steady in Q1 2026 at 19 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #7432.

JP Morgan Chase first reported a position in PDSB in Q4 2015 and has held it in 22 quarters since. The position peaked at $4.06M in Q3 2017. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • JP Morgan Chase held 19 shares of PDS Biotechnology worth $10 as of Q1 2026.
  • JP Morgan Chase left its PDS Biotechnology share count unchanged in Q1 2026.
  • PDS Biotechnology made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7432 holding.
  • JP Morgan Chase first reported a position in PDS Biotechnology in Q4 2015 and has held it in 22 quarters since.
  • JP Morgan Chase's PDS Biotechnology position peaked at $4.06M in Q3 2017.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.